411 related articles for article (PubMed ID: 17449257)
21. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.
Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ
J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943
[TBL] [Abstract][Full Text] [Related]
23. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-17 is involved in orthodontically induced inflammatory root resorption in dental pulp cells.
Nakano Y; Yamaguchi M; Shimizu M; Kikuta J; Yoshino T; Tanimoto Y; Kasai K
Am J Orthod Dentofacial Orthop; 2015 Aug; 148(2):302-9. PubMed ID: 26232839
[TBL] [Abstract][Full Text] [Related]
25. [Effect of different types of jumps on the expressions of IL-6, OPG and RANKL in rat tibia].
Wang T; Zhang X; Li S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):909-12. PubMed ID: 25200151
[TBL] [Abstract][Full Text] [Related]
26. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
[TBL] [Abstract][Full Text] [Related]
27. The function and meaning of receptor activator of NF-κB ligand in arterial calcification.
Nie B; Zhou SQ; Fang X; Zhang SY; Guan SM
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):666-671. PubMed ID: 26489619
[TBL] [Abstract][Full Text] [Related]
28. Osteoclasts are not activated in middle ear cholesteatoma.
Koizumi H; Suzuki H; Ikezaki S; Ohbuchi T; Hashida K; Sakai A
J Bone Miner Metab; 2016 Mar; 34(2):193-200. PubMed ID: 25796629
[TBL] [Abstract][Full Text] [Related]
29. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
30. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
[TBL] [Abstract][Full Text] [Related]
31. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
[TBL] [Abstract][Full Text] [Related]
32. Diverse osteoclastogenesis of bone marrow from mandible versus long bone.
Chaichanasakul T; Kang B; Bezouglaia O; Aghaloo TL; Tetradis S
J Periodontol; 2014 Jun; 85(6):829-36. PubMed ID: 24003963
[TBL] [Abstract][Full Text] [Related]
33. Environmental level of cadmium exposure stimulates osteoclasts formation in male rats.
Chen X; Wang G; Li X; Gan C; Zhu G; Jin T; Wang Z
Food Chem Toxicol; 2013 Oct; 60():530-5. PubMed ID: 23954550
[TBL] [Abstract][Full Text] [Related]
34. Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.
Ainola M; Mandelin J; Liljeström M; Konttinen YT; Salo J
Clin Exp Rheumatol; 2008; 26(2):240-6. PubMed ID: 18565244
[TBL] [Abstract][Full Text] [Related]
35. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
Jin Q; Cirelli JA; Park CH; Sugai JV; Taba M; Kostenuik PJ; Giannobile WV
J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585
[TBL] [Abstract][Full Text] [Related]
36. Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats.
Miyazaki T; Matsunaga T; Miyazaki S; Hokari S; Komoda T
J Cell Biochem; 2004 Oct; 93(3):503-12. PubMed ID: 15372622
[TBL] [Abstract][Full Text] [Related]
37. Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats.
Zhou J; Chen S; Guo H; Xia L; Liu H; Qin Y; He C
Rheumatol Int; 2013 May; 33(5):1135-41. PubMed ID: 22948539
[TBL] [Abstract][Full Text] [Related]
38. Receptor activator of nuclear factor-κB ligand and sclerostin expression in osteocytes of alveolar bone in rats with ligature-induced periodontitis.
Kim JH; Lee DE; Cha JH; Bak EJ; Yoo YJ
J Periodontol; 2014 Nov; 85(11):e370-8. PubMed ID: 25070541
[TBL] [Abstract][Full Text] [Related]
39. The effect of etidronate on the periodontium of ovariectomized rats.
Said F; Ghoul-Mazgar S; Khemiss F; El Ayeb H; Saidane D; Berdal A; Ruhin-Poncet B
J Periodontol; 2012 Aug; 83(8):1063-8. PubMed ID: 22166164
[TBL] [Abstract][Full Text] [Related]
40. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
